{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:58:09Z","timestamp":1791899889520,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","award":["APP1099452"],"award-info":[{"award-number":["APP1099452"]}],"id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1117065"],"award-info":[{"award-number":["APP1117065"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ijantimicag.2018.09.021","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T02:25:29Z","timestamp":1538706329000},"page":"137-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis"],"prefix":"10.1016","volume":"53","author":[{"given":"Jacob","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahipal G.","family":"Sinnollareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Peake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0001","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/CCM.0b013e31827c09f8","article-title":"Benchmarking the incidence and mortality of severe sepsis in the United States","volume":"41","author":"Gaieski","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0002","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1186\/s13054-014-0654-2","article-title":"Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram","volume":"18","author":"Baptista","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0003","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s13054-014-0632-8","article-title":"Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study","volume":"18","author":"Donadello","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0004","first-page":"R99","article-title":"Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients?","volume":"18","author":"Blot","year":"2014","journal-title":"Data from the multinational DALI study. Crit Care"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0005","first-page":"23","article-title":"Pharmacokinetics of antibiotics in tissues and tissue fluids: a review","volume":"74","author":"Cars","year":"1990","journal-title":"Scand J Infect Dis Suppl"},{"issue":"Suppl D","key":"10.1016\/j.ijantimicag.2018.09.021_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/31.suppl_D.1","article-title":"Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans","volume":"31","author":"Ryan","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0007","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jac\/dkp139","article-title":"Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution","volume":"64","author":"Roberts","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0008","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00003246-200102000-00030","article-title":"Impaired target site penetration of \u03b2-lactams may account for therapeutic failure in patients with septic shock","volume":"29","author":"Joukhadar","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0009","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Infectious Diseases Society of America. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00134-005-0015-3","article-title":"Levels of vancomycin in the cerebral interstitial fluid after severe head injury","volume":"32","author":"Caricato","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0011","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1128\/AAC.50.4.1372-1375.2006","article-title":"Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery","volume":"50","author":"Skhirtladze","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0012","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2125.2010.03679.x","article-title":"Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic\/pharmacodynamic simulation","volume":"70","author":"Revilla","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0013","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2165\/00003088-200544090-00002","article-title":"Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future","volume":"44","author":"Joukhadar","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0014","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0015","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.02461-15","article-title":"In vivo microdialysis to determine subcutaneous interstitial fluid penetration and pharmacokinetics of fluconazole in intensive care unit patients with sepsis","volume":"60","author":"Sinnollareddy","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0016","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1023\/A:1011992125204","article-title":"Methodological aspects of the use of a calibrator in in vivo microdialysis\u2014further development of the retrodialysis method","volume":"15","author":"Bouw","year":"1998","journal-title":"Pharm Res"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0017","series-title":"Guidance for industry\u2014bioanalytical method validation, draft guidance","year":"2013"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0018","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","article-title":"Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R","volume":"34","author":"Neely","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0019","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7547\/14-033","article-title":"Vancomycin tissue pharmacokinetics in patients with lower-limb infections via in vivo microdialysis","volume":"105","author":"Housman","year":"2015","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.ijantimicag.2018.09.021_bib0020","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/CCM.0b013e3181968e44","article-title":"Piperacillin penetration into tissue of critically ill patients with sepsis\u2014bolus versus continuous administration?","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918302802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918302802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T13:42:10Z","timestamp":1565271730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918302802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0924857918302802"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.09.021","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}